March 22, 2017 / 12:07 PM / 5 months ago

BRIEF-Karolinska Development: research collaboration with Memorial Sloan Kettering Cancer Center

March 22 (Reuters) - Karolinska Development AB:

* Karolinska Development company Aprea Therapeutics announces research collaboration with Memorial Sloan Kettering Cancer Center

* Announced a collaboration with Memorial Sloan Kettering Cancer Center to study the effects of reactivation of tumor suppressor protein p53 by APR-246 Source text for Eikon: Further company coverage: (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below